LYNSI BLANCHARD: Open Payments
NPI 1780170134 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 24 payments from 6 companies in 2025. Trend: 2023 $321 · 2024 $414 · 2025 $682
Food & beverage: $582Education: $100
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 10 | $379 |
| Axsome Therapeutics, Inc. | 8 | $179 |
| ABBVIE INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $39 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $22 |
| HARMONY BIOSCIENCES LLC | 1 | $16 |
Products named: XYWAV, Sunosi, QULIPTA, ZEPBOUND, LUMRYZ, WAKIX.
Industry payments across LA — which companies pay providers there.
